Chesnara Plc: Fourth acquisition in two years
12 November 2026
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is making waves in the biotechnology sector with its promising pipeline of treatments targeting neurodegenerative and endocrine conditions. As a clinical-stage..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a burgeoning player in the biotechnology sector, is catching the eye of investors with its promising pipeline and a staggering potential..
REGENXBIO Inc. (RGNX), a clinical-stage biotechnology company, could be a compelling opportunity for investors seeking exposure to the gene therapy sector. With a proprietary NAV Technology..
Relay Therapeutics, Inc. (NASDAQ: RLAY) captures the attention of investors with its innovative approach to drug discovery, despite its volatile stock performance. With a market capitalization..
Avanos Medical, Inc. (NYSE: AVNS) operates at the intersection of innovation and healthcare. Specializing in medical devices, Avanos is a key player in delivering solutions that..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, operating within the drug manufacturers’ specialty and generic industry. With a market capitalization of $417.28..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the biotech industry’s next big leap with its innovative gene editing technologies. As a clinical-stage company..
For investors looking to tap into the burgeoning biotechnology sector, AbCellera Biologics Inc. (NASDAQ: ABCL) presents a compelling opportunity. Based in Vancouver, Canada, AbCellera is at..
Neuropace, Inc. (NPCE), a pioneering entity in the healthcare sector, is capturing investor attention with its cutting-edge medical devices aimed at treating drug-resistant focal epilepsy. With..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is making significant waves with its promising pipeline of drug therapies. With a market..
Ardelyx, Inc. (NASDAQ: ARDX) is drawing significant attention in the biotechnology space, promising a potential upside that has investors watching closely. With a market capitalization of..
For investors keen on the healthcare sector, Akso Health Group (NASDAQ: AHG) presents an intriguing opportunity, buoyed by an impressive 676% revenue growth. Headquartered in Qingdao,..
Delcath Systems, Inc. (NASDAQ: DCTH), a healthcare innovator in the medical devices sector, has recently caught the attention of investors with its remarkable potential upside of..
Gyre Therapeutics, Inc. (NASDAQ: GYRE) is making waves in the biotechnology sector with its promising pipeline of anti-inflammatory and anti-fibrotic drugs. Based in San Diego, California,..
Regulus Therapeutics Inc. (NASDAQ: RGLS), a player in the innovative biotechnology sector, is capturing investor attention with its focus on developing treatments for genetically based orphan..
For individual investors seeking opportunities in the healthcare sector, OrthoPediatrics Corp. (NASDAQ: KIDS) presents a compelling case. This U.S.-based medical device company specializes in developing and..
For investors seeking opportunities in the biotechnology sector, uniQure N.V. (NASDAQ: QURE) presents a compelling consideration. With a market capitalization of $815.21 million, this Netherlands-based biotech..
CureVac N.V. (NASDAQ: CVAC), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative mRNA technology. Based in Tübingen, Germany, CureVac focuses on..
